Table 3.
Lagging-strand mutations | T → C | G → A | T → A | T → G | C → A | G → C | Total |
---|---|---|---|---|---|---|---|
hTK | |||||||
Total | 12 | 64 | 14 | 4 | 1 | 2 | 97 |
OP sites | 5 | 18 | 2 | 0 | 0 | 0 | 25 |
Overrepresentation (fold) | 10.4 | 7.0 | 3.6 | 0.0 | 0.0 | 0.0 | |
Normalized for nucleotide composition (fold) | 7.8 | 4.1 | 2.7 | N/A | N/A | N/A | |
GFP | |||||||
Total | 12 | 38 | 16 | 2 | 7 | 5 | 80 |
OP sites | 2 | 5 | 5 | 1 | 1 | 4 | 18 |
Overrepresentation (fold) | 2.9 | 2.3 | 5.4 | 8.6 | 2.5 | 13.8 | |
Normalized for nucleotide composition (fold) | 2.7 | 1.3 | 5.1 | 8.1 | 4.3 | 8.1 | |
hTK and GFP | |||||||
Total | 24 | 102 | 30 | 6 | 8 | 7 | 177 |
OP sites | 7 | 23 | 7 | 1 | 1 | 4 | 43 |
Overrepresentation (fold) | 5.4 | 4.2 | 4.3 | 3.1 | 2.3 | 10.6 | |
Normalized for nucleotide composition (fold) | 4.5 | 2.5 | 3.6 | 2.6 | 4.9 | 6.4 |
Overrepresentation is defined as the percent of a given marker lagging-strand mutation within OP sites relative to the percent of the total, considering the fraction of sequence represented by these sites; in the case of hTK OP sites represent 4% of the total coverage, and in the case of GFP OP sites represent 5.8%. These values for overrepresentation were normalized by dividing the overrepresentation values by a ‘nucleotide composition bias factor’, a fudge factor expressing the relative abundance of individual nucleotides within OP sites (Supplementary Table S3). Values we were unable to calculate due to gaps in our data are indicated as N/A.